Testing an HPV Vaccine Decision Aid for 27- to 45-Year-Old Adults in the United States: A Randomized Trial
Shared clinical decision making is recommended for HPV vaccination with mid-adults.A patient decision aid for HPV vaccination reduced decisional conflict for mid-adults.The HPV vaccine patient decision aid was acceptable to mid-adults.
Authors
- Jessica Grace
- Gregory D. Zimet (ORCID: https://orcid.org/0000-0003-3835-937X)
- Erika L. Thompson (ORCID: https://orcid.org/0000-0002-7115-0001)
- Ellen M. Daley (ORCID: https://orcid.org/0000-0003-3020-295X)
- Idara N. Akpan (ORCID: https://orcid.org/0000-0003-2993-2939)
- Justin M. Luningham (ORCID: https://orcid.org/0000-0002-5037-9149)
- Christopher W. Wheldon (ORCID: https://orcid.org/0000-0002-0452-0252)
- Sarah A. Alkhatib (ORCID: https://orcid.org/0009-0008-3185-710X)
Institutions
- University of North Texas (US)
- Texas Christian University (US)
- University of North Texas Health Science Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of South Florida (US)
- Indiana University – Purdue University Indianapolis (US)
- Temple University (US)
Publication Details
- Journal
- Medical Decision Making
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1177/0272989x241305142
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- University of North Texas
- Moderna